STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCTION OF APO-B LEVELS

摘要

Methods of utilizing a combined administration or a unit dosage of a comb ination of an HMG-CoA inhibitor and omega-3 fatty acids for the reduction of apolipoprotein-B levels. The methods are especially useful in the treatment of- patients with hypertriglyceridemia or hypercholesterolemia or mixed dys lipidemia, coronary heart disease (CHD), vascular disease, atherosclerotic d isease and related conditions, and for the prevention or reduction of cardio vascular, cardiac, and vascular events.